In yesterday’s Wall Street session, Silk Road Medical Inc (NASDAQ:SILK) shares traded at $26.96, up 0.30% from the previous session.
SILK stock price is now 32.56% away from the 50-day moving average and 78.49% away from the 200-day moving average. The market capitalization of the company currently stands at $1.06B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $24, Argus recently Upgraded its rating from Hold to Buy for Silk Road Medical Inc (NASDAQ: SILK). On January 19, 2024, Stifel Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock increasing its target price from $9 to quote $20, while ‘Lake Street’ rates the stock as ‘Buy’
In other news, Ballinger Kevin J., Director bought 11,700 shares of the company’s stock on Mar 05 ’24. The stock was bought for $198,783 at an average price of $16.99. Upon completion of the transaction, the Director now directly owns 17,807 shares in the company, valued at $0.48 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 05 ’24, COO/CFO Buchanan Lucas W. sold 9,877 shares of the business’s stock. A total of $169,578 was realized by selling the stock at an average price of $17.17. This leaves the insider owning 500,925 shares of the company worth $13.5 million. A total of 9.15% of the company’s stock is owned by insiders.
During the past 12 months, Silk Road Medical Inc has had a low of $6.08 and a high of $34.13. As of last week, the company has a debt-to-equity ratio of 0.57, a current ratio of 11.05, and a quick ratio of 9.62. The fifty day moving average price for SILK is $20.513 and a two-hundred day moving average price translates $15.141125 for the stock.
The latest earnings results from Silk Road Medical Inc (NASDAQ: SILK) was released for 2024-03-31. The net profit margin was -28.80% and return on equity was -35.04% for SILK. The company reported revenue of $48.48 million for the quarter, compared to $40.13 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 20.81 percent.
